Collegium Pharmaceutical, Inc. Prepaid Expense, Current
Collegium Pharmaceutical, Inc. (COLL) had Prepaid Expense, Current of $7.27 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2025-02-27
- 2024-12-31: Prepaid Expense, Current $7.27M.
- 2023-12-31: Prepaid Expense, Current $5.94M.
- 2022-12-31: Prepaid Expense, Current $5.61M.
- 2021-12-31: Prepaid Expense, Current $3.60M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2024-12-31 | $7.27M 10-K · filed 2025-02-27 |
| 2023-12-31 | $5.94M 10-K · filed 2025-02-27 |
| 2022-12-31 | $5.61M 10-K · filed 2024-02-22 |
| 2021-12-31 | $3.60M 10-K · filed 2023-02-23 |
| 2020-12-31 | $3.28M 10-K · filed 2022-02-24 |
| 2019-12-31 | $1.22M 10-K · filed 2021-02-25 |
| 2018-12-31 | $3.04M 10-K · filed 2020-02-27 |
| 2017-12-31 | $1.43M 10-K · filed 2019-02-27 |
| 2016-12-31 | $512.00K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |